4.6 Article

Repression of Arginase-2 Expression in Dendritic Cells by MicroRNA-155 Is Critical for Promoting T Cell Proliferation

Journal

JOURNAL OF IMMUNOLOGY
Volume 193, Issue 4, Pages 1690-1700

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1301913

Keywords

-

Categories

Funding

  1. Swiss National Science Foundation [3100A0-105895, PZ00P3-131945, PDFM33-118375, 310030-138338]
  2. Geneva Cancer League
  3. Swiss Cancer League (Oncosuisse)
  4. Ernst and Lucy Schmidheiny Foundation
  5. Swiss Multiple Sclerosis Society
  6. National Center of Competence in Research on Neural Plasticity and Repair
  7. European Union Framework Program 6 consortium Dendritic Cell Therapy (DC-THERA)
  8. Marie Heim-Vogtlin Programme
  9. Swiss Pneumology Society
  10. Swiss National Science Foundation (SNF) [PDFM33-118375, PZ00P3_131945, 310030_138338] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Arginine, a semiessential amino acid implicated in diverse cellular processes, is a substrate for two arginases-Arg1 and Arg2-having different expression patterns and functions. Although appropriately regulated Arg1 expression is critical for immune responses, this has not been documented for Arg2. We show that Arg2 is the dominant enzyme in dendritic cells (DCs) and is repressed by microRNA-155 (miR155) during their maturation. miR155 is known to be strongly induced in various mouse and human DC subsets in response to diverse maturation signals, and miR155-deficient DCs exhibit an impaired ability to induce Ag-specific T cell responses. By means of expression profiling studies, we identified Arg2 mRNA as a novel miR155 target in mouse DCs. Abnormally elevated levels of Arg2 expression and activity were observed in activated miR155-deficient DCs. Conversely, overexpression of miR155 inhibited Arg2 expression. Bioinformatic and functional analyses confirmed that Arg2 mRNA is a direct target of miR155. Finally, in vitro and in vivo functional assays using DCs exhibiting deregulated Arg2 expression indicated that Arg2-mediated arginine depletion in the extracellular milieu impairs T cell proliferation. These results indicate that miR155-induced repression of Arg2 expression is critical for the ability of DCs to drive T cell activation by controlling arginine availability in the extracellular environment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available